Vascular Surgery Research Group, Imperial College London, Charing Cross Hospital, London, UK.
Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Lancet. 2017 Jun 24;389(10088):2482-2491. doi: 10.1016/S0140-6736(17)30639-6. Epub 2017 Apr 25.
Prognosis for women with abdominal aortic aneurysm might be worse than the prognosis for men. We aimed to systematically quantify the differences in outcomes between men and women being assessed for repair of intact abdominal aortic aneurysm using data from study periods after the year 2000.
In these systematic reviews and meta-analysis, we identified studies (randomised, cohort, or cross-sectional) by searching MEDLINE, Embase, CENTRAL, and grey literature published between Jan 1, 2005, and Sept 2, 2016, for two systematic reviews and Jan 1, 2009, and Sept 2, 2016, for one systematic review. Studies were included if they were of both men and women, with data presented for each sex separately, with abdominal aortic aneurysms being assessed for aneurysm repair by either endovascular repair (EVAR) or open repair. We conducted three reviews based on whether studies reported the proportion morphologically suitable (within manufacturers' instructions for use) for EVAR (EVAR suitability review), non-intervention rates (non-intervention review), and 30-day mortality (operative mortality review) after intact aneurysm repair. Studies had to include at least 20 women (for the EVAR suitability review), 20 women (for the non-intervention review), and 50 women (for the operative mortality review). Studies were excluded if they were review articles, editorials, letters, or case reports. For the operative review, studies were also excluded if they only provided hazard ratios or only reported in-hospital mortality. We assessed the quality of the studies using the Newcastle-Ottawa scoring system, and contacted authors for the provision of additional data if needed. We combined results across studies by random-effects meta-analysis. This study is registered with PROSPERO, number CRD42016043227.
Five studies assessed the morphological eligibility for EVAR (1507 men, 400 women). The overall pooled proportion of women eligible (34%) for EVAR was lower than it was in men (54%; odds ratio [OR] 0·44, 95% CI 0·32-0·62). Four single-centre studies reported non-intervention rates (1365 men, 247 women). The overall pooled non-intervention rates were higher in women (34%) than men (19%; OR 2·27, 95% CI 1·21-4·23). The review of 30-day mortality included nine studies (52 018 men, 11 076 women). The overall pooled estimate for EVAR was higher in women (2·3%) than in men (1·4%; OR 1·67, 95% CI 1·38-2·04). The overall estimate for open repair also was higher in women (5·4%) than in men (2·8%; OR 1·76, 95% CI 1·35-2·30).
Compared with men, a smaller proportion of women are eligible for EVAR, a higher proportion of women are not offered intervention, and operative mortality is much higher in women for both EVAR and open repair. The management of abdominal aortic aneurysm in women needs improvement.
National Institute for Health Research (UK).
女性腹主动脉瘤的预后可能比男性差。我们旨在使用 2000 年后研究期间的数据,系统地量化在评估腹主动脉瘤修复时男性和女性之间结局的差异。
在这些系统评价和荟萃分析中,我们通过检索 MEDLINE、Embase、CENTRAL 和灰色文献,于 2005 年 1 月 1 日至 2016 年 9 月 2 日为两项系统评价和 2009 年 1 月 1 日至 2016 年 9 月 2 日为一项系统评价确定了研究(随机、队列或横断面)。如果研究为男女两性,且分别为每一种性别提供数据,并且通过血管内修复(EVAR)或开放修复评估腹主动脉瘤修复的可能性,则将其纳入研究。我们进行了三项基于研究是否报告了形态学适合(制造商使用说明范围内)EVAR(EVAR 适合性评价)、非干预率(非干预评价)和 30 天死亡率(手术死亡率评价)的评价。EVAR 适合性评价至少需要 20 名女性,非干预评价至少需要 20 名女性,手术死亡率评价至少需要 50 名女性。如果研究为综述文章、社论、信件或病例报告,则将其排除。对于手术评价,如果研究只提供了危险比或只报告了院内死亡率,也将其排除。我们使用纽卡斯尔-渥太华量表评估研究的质量,如果需要,我们会联系作者以获取更多数据。我们通过随机效应荟萃分析合并研究结果。本研究在 PROSPERO 注册,编号 CRD42016043227。
五项研究评估了 EVAR 的形态学适宜性(1507 名男性,400 名女性)。女性适合 EVAR 的总体比例(34%)低于男性(54%;比值比[OR]0·44,95%CI 0·32-0·62)。四项单中心研究报告了非干预率(1365 名男性,247 名女性)。女性的总体非干预率(34%)高于男性(19%;OR 2·27,95%CI 1·21-4·23)。30 天死亡率评价包括 9 项研究(52018 名男性,11076 名女性)。女性的 EVAR 总体估计值高于男性(2·3%比 1·4%;OR 1·67,95%CI 1·38-2·04)。女性开放修复的总体估计值也高于男性(5·4%比 2·8%;OR 1·76,95%CI 1·35-2·30)。
与男性相比,女性适合 EVAR 的比例较小,不建议进行干预的女性比例较高,并且女性的 EVAR 和开放修复手术死亡率都高得多。女性腹主动脉瘤的管理需要改进。
英国国家健康研究所(UK)。